Korean J Psychopharmacol.  2010 Jul;21(3):144-149.

Effect of Temperament and Character on Pharmacotherapy in Panic Disorder Patients

Affiliations
  • 1Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. bhyu@skku.edu

Abstract


OBJECTIVE
Temperament and character that represent personality trait are supposed to relate to panic disorder (PD). There are several studies that report a significant relationship among temperament, character and treatment outcome in PD. In this study, we examined whether temperament and character affect the long term outcome of escitalopram treatment in patients with PD.
METHODS
Ninety-two patients with PD were recruited at the psychiatric outpatient clinics of 6 university hospitals in South Korea. All patients were treated with escitalopram for 6 months. The Temperament-Character Inventory-Revised-Short (TCI-RS) was administered to all patients at baseline. They were also assessed with the Panic Disorder Severity Scale (PDSS), Hamilton Rating Scale for Anxiety (HAM-A), 17-item Hamilton Rating Scale for Depression (HAMD-17), and Clinical Global Impression on-Severity (CGI-S) at both baseline and after 6 months of pharmacotherapy.
RESULTS
There was a significant relationship between reward dependence (RD) and a remission rate in PD patients who were treated with escitalopram, and panic patients who had high RD showed a low remission rate after the treatment.
CONCLUSION
This study suggests that high RD predicts a poor treatment response in patients with PD.

Keyword

TCI; Panic; Treatment response; Temperament and character

MeSH Terms

Ambulatory Care Facilities
Anxiety
Citalopram
Depression
Hospitals, University
Humans
Panic
Panic Disorder
Polymethacrylic Acids
Republic of Korea
Reward
Temperament
Treatment Outcome
Citalopram
Polymethacrylic Acids
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr